OpenVSafe by OpenVAERS
Search V-safe

BJZ-31928-35662

1 vaccination 5 coded responses 6 check-ins 5 free-text entries 3 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
125 / NY
Registered
2021-01-17
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Moderna
  2. 2021-01-17
    Registered in v-safe
  3. 2021-01-17
    Survey response — day 14, dose 1
    MedDRA: Arthralgia, Chills, Feeling abnormal, Headache, Hypoaesthesia, Lip blister, Myalgia, Oral mucosal blistering, Pyrexia, Tongue blistering — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: 24 hours after vaccine, developed debilitating muscle and joint aches, mouth, tongue and lips broke out in blisters, hands went numb, fever > 103, chills and rigors. Woke up next day with debilitating headache and brain fog.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-17
    Report sent to call center — day 14, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-01-19
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  6. 2021-01-26
    Survey response — day 28, dose 1
    MedDRA: Headache, Palpitations — Feeling: Fair · Be unable to do your normal daily activities
    Free text: More intense headaches, heart palpitations
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-02
    Survey response — day 35, dose 1
    MedDRA: Headache — Feeling: Fair
    Free text: Headaches are intermittently more intense
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-07-01
    Survey response — 6 months, dose 1
    MedDRA: Blindness unilateral, Deafness unilateral, Neuropathy peripheral, Pain, Postural orthostatic tachycardia syndrome, Pre-existing disease, Visual impairment — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: POTS when standing up, hearing loss L ear, visions impaired L eye, increased pain, neuropathy lower extremities,
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-07-01
    Report sent to call center — 6 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  10. 2021-07-04
  11. 2021-12-29
    Survey response — 12 months, dose 1
    MedDRA: Headache, Mast cell activation syndrome, Neuropathy peripheral, Rash, Tic — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Daily headaches, peripheral neuropathy, rash, facial tics, mast cell activation syndrome
    MedDRA releases: 2024-11 · check-in free text available
  12. 2021-12-29
    Report sent to call center — 12 months, dose 1
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  13. 2022-01-03
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Moderna

Call center

3 call center cases

2 successful · 1 priority 2/3 (triaged and no follow up)

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 2 — day 14, dose 1

2021-01-17

Symptoms: 24 hours after vaccine, developed debilitating muscle and joint aches, mouth, tongue and lips broke out in blisters, hands went numb, fever > 103, chills and rigors. Woke up next day with debilitating headache and brain fog.

Release 2 — day 28, dose 1

2021-01-26

Symptoms: More intense headaches, heart palpitations

Release 3 — day 35, dose 1

2021-02-02

Symptoms: Headaches are intermittently more intense

Release 9 — 6 months, dose 1

2021-07-01

Symptoms: POTS when standing up, hearing loss L ear, visions impaired L eye, increased pain, neuropathy lower extremities,

Release 10 — 12 months, dose 1

2021-12-29

Symptoms: Daily headaches, peripheral neuropathy, rash, facial tics, mast cell activation syndrome

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDBlindness unilateral ○ ✓ ○
SDChills ✓ ✓ ✓
SDDeafness unilateral ✓ ✓ ✓
SDFeeling abnormal ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHypoaesthesia ✓ ✓ ✓
SDLip blister ✓ ✓ ✓
SDMast cell activation syndrome · · ✓
SDMyalgia ✓ ✓ ✓
SDNeuropathy peripheral ✓ · ✓
SDOral mucosal blistering ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDPalpitations ✓ ✓ ✓
SDPostural orthostatic tachycardia syndrome ✓ ✓ ✓
SDPre-existing disease ○ ✓ ○
SDPyrexia ✓ ✓ ✓
SDRash · · ✓
SDTic · · ✓
SDTongue blistering ✓ ✓ ✓
SDVisual impairment ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release